Status:
COMPLETED
Reducing Symptoms of Multiple Sclerosis Using Non-invasive Neuromodulation
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study sought to examine the effect of targeted physical therapy with and without cranial nerve non-invasive neuromodulation (CN-NINM), on the walking ability of people with MS who exhibited a dys...
Detailed Description
Background: This study sought to examine the effect of targeted physical therapy with and without cranial nerve non-invasive neuromodulation (CN-NINM), on the walking ability of people with MS who exh...
Eligibility Criteria
Inclusion
- All subjects are initially evaluated for inclusion/exclusion on the Kurtzke Expanded Disability Status Scale (EDSS), a test typically administered by their healthcare provider as an ongoing part of standard therapy for M.S
- Relapsing remitting MS ("RRMS"), primary progressive MS ("PPMS"), or secondary progressive MS ("SPMS") without relapse within 6 months of enrollment;
- EDSS score of 3.0 - 6.0 ;
- No changes in medication within 3 months of enrollment;
- Ability to walk 20 minutes on a treadmill (with handrail support as needed) without rest;
- Provided informed consent and willing to participate.
Exclusion
- • Major co-morbidities, especially other neurological disorders, uncontrolled pain, hypertension, diabetes, or oral health problems
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04498039
Start Date
November 1 2009
End Date
May 1 2011
Last Update
August 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.